Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion

[1]  M. Sakaguchi,et al.  A super gene expression system enhances the anti-glioma effects of adenovirus-mediated REIC/Dkk-3 gene therapy , 2016, Scientific Reports.

[2]  J. D. de Groot,et al.  Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models. , 2016, Neuro-oncology.

[3]  P. Taimen,et al.  Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy , 2016, International journal of cancer.

[4]  I. Date,et al.  Phenotypic Transition as a Survival Strategy of Glioma , 2016, Neurologia medico-chirurgica.

[5]  K. Takata,et al.  Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization , 2016, Scientific Reports.

[6]  Thomas C. Chen,et al.  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. , 2015, JAMA.

[7]  Lijun Yang,et al.  Nuclear translocation of fibroblast growth factor-2 (FGF2) is regulated by Karyopherin-β2 and Ran GTPase in human glioblastoma cells , 2015, Oncotarget.

[8]  M. Reginato,et al.  Emerging microtubule targets in glioma therapy. , 2015, Seminars in pediatric neurology.

[9]  Christopher M. Fife,et al.  Movers and shakers: cell cytoskeleton in cancer metastasis , 2014, British journal of pharmacology.

[10]  Songbin Fu,et al.  siRNA targeting stathmin inhibits invasion and enhances chemotherapy sensitivity of stem cells derived from glioma cell lines. , 2014, Acta biochimica et biophysica Sinica.

[11]  I. Date,et al.  Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma , 2014, Brain Tumor Pathology.

[12]  T. Mikkelsen,et al.  Sox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiation. , 2014, Neoplasia.

[13]  K. Aldape,et al.  A randomized trial of bevacizumab for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[14]  K. Hoang-Xuan,et al.  Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[15]  Diane D. Liu,et al.  A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor‐Initiating Cells , 2014, Stem cells.

[16]  K. Tomizawa,et al.  Cyclin G2 promotes hypoxia-driven local invasion of glioblastoma by orchestrating cytoskeletal dynamics. , 2013, Neoplasia.

[17]  T. Okada,et al.  Upregulated expression of FGF13/FHF2 mediates resistance to platinum drugs in cervical cancer cells , 2013, Scientific Reports.

[18]  I. Date,et al.  Proteomics‐based analysis of invasion‐related proteins in malignant gliomas , 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.

[19]  I. Date,et al.  Bimodal anti‐glioma mechanisms of cilengitide demonstrated by novel invasive glioma models , 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.

[20]  T. Chan,et al.  Valproic acid use during radiation therapy for glioblastoma associated with improved survival. , 2012, International journal of radiation oncology, biology, physics.

[21]  J. Heymach,et al.  Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype. , 2012, Neuro-oncology.

[22]  D. Cheresh,et al.  VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. , 2012, Cancer cell.

[23]  R. Berges,et al.  A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration, and inducing apoptosis. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  Shuai Li,et al.  Fibroblast Growth Factor 13 Is a Microtubule-Stabilizing Protein Regulating Neuronal Polarization and Migration , 2012, Cell.

[25]  Y. Yonekawa,et al.  Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial , 2012, Oncology.

[26]  T. Tokuyasu,et al.  Microarray Analysis Verifies Two Distinct Phenotypes of Glioblastomas Resistant to Antiangiogenic Therapy , 2012, Clinical Cancer Research.

[27]  Stephen Yip,et al.  Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells. , 2012, Neuro-oncology.

[28]  S. Mörk,et al.  Microtubule-Severing ATPase Spastin in Glioblastoma: Increased Expression in Human Glioblastoma Cell Lines and Inverse Roles in Cell Motility and Proliferation , 2011, Journal of neuropathology and experimental neurology.

[29]  H. Seol,et al.  Role of the cofilin activity cycle in astrocytoma migration and invasion. , 2011, Genes & cancer.

[30]  T. Taxt,et al.  Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma , 2011, Proceedings of the National Academy of Sciences.

[31]  I. Date,et al.  Angiogenesis and invasion in glioma , 2011, Brain Tumor Pathology.

[32]  Wei Yu,et al.  The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis , 2011, BMC Genomics.

[33]  Khalid Shah,et al.  Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. , 2009, Cancer research.

[34]  E. Nishida,et al.  Fibroblast Growth Factor 13 Is Essential for Neural Differentiation in Xenopus Early Embryonic Development* , 2007, Journal of Biological Chemistry.

[35]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[36]  A. M. Rush,et al.  Fibroblast Growth Factor Homologous Factor 2B: Association with Nav1.6 and Selective Colocalization at Nodes of Ranvier of Dorsal Root Axons , 2004, Journal of Neuroscience.

[37]  D. Louis,et al.  Potentiated gene delivery to tumors using herpes simplex virus/Epstein-Barr virus/RV tribrid amplicon vectors. , 2003, Human gene therapy.

[38]  J. Nathans,et al.  Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Coons,et al.  Tumorigenic, invasive, karyotypic, and immunocytochemical characteristics of clonal cell lines derived from a spontaneous canine anaplastic astrocytoma , 1993, In Vitro Cellular & Developmental Biology - Animal.

[40]  H. Scherer.  A CRITICAL REVIEW , 1940, Journal of neurology and psychiatry.

[41]  石田 穣治.  Integrin Inhibitor Suppresses Bevacizumab-Induced Glioma Invasion , 2014 .

[42]  井上 智.  Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas , 2012 .

[43]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[44]  R. Weissleder,et al.  MRI of transgene expression: correlation to therapeutic gene expression. , 2002, Neoplasia.